@article{TLCR20040,
author = {Biagio Ricciuti and Rita Chiari},
title = {First line osimertinib for the treatment of patients with advanced EGFR-mutant NSCLC},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {Molecular profiling in patients with newly diagnosed advanced non-small cell lung cancer (NSCLC) has become routine in clinical practice, allowing us to provide the most effective treatment to individuals harboring actionable genetic alterations.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/20040}
}